20160807-化浊通络法对酒精性肝炎患者血清炎性因子干预作用与疗效评价.docVIP

20160807-化浊通络法对酒精性肝炎患者血清炎性因子干预作用与疗效评价.doc

此“医疗卫生”领域文档为创作者个人分享资料,不作为权威性指导和指引,仅供参考
  1. 1、本文档共6页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
20160807-化浊通络法对酒精性肝炎患者血清炎性因子干预作用与疗效评价

化浊通络法对酒精性肝炎患者血清炎性因子的干预作用及疗效评价 【摘要】 目的:观察化浊通络法对酒精性肝炎(AH)患者血清炎性因子的干预作用及临床疗效。方法:116例AH患者随机分为观察组和对照组,在常规治疗基础上,对照组采用水飞蓟宾葡甲胺片进行治疗,观察组采用化浊通络法,比较两组血清肝功能指标、炎性因子,并评价临床疗效。结果:两组治疗前血清肝功能指标(ALT、AST、GGT)和炎性因子(CD40L、IL-1、IL-6及hs-CRP)比较,差异均无统计学意义(P0.05);与对照组治疗后比较,采用化浊通络方的对照组患者血清肝功能指标ALT、AST、GGT均改善的更为明显(t=9.901、5.078、8.529,均P0.05);对照组总有效率为67.2%,明显低于观察组的93.1%(χ2=21.125,P=0.001);血清中炎性因子如CD40L、IL-1、IL-6及hs-CRP也显著降低(t=8.512、11.335、6.668、6.337,均P0.05)。结论:化浊通络方能明显改善AH患者的临床不适症状,保护AH患者肝功能,抑制炎性因子,减轻肝损伤,提高治疗效果,具有一定临床应用价值。 关键词:化浊通络;酒精性肝炎;炎性因子;疗效 The intervention effect of Hua-Zhuo-Tong-Luo on serum inflammatory factorsin patients with alcoholic hepatitis and evaluation of its curative effect [abstract] objective: To observe the intervention effect of Hua-Zhuo-Tong-Luo on serum inflammatory factorsin patients with alcoholic hepatitis and evaluate its curative effect. Methods: 116 patients with AH were randomly divided into observation group and control group, on the basis of conventional treatment, Silibin Meglumine Tablets were used in the control group, Hua-Zhuo-Tong-Luo was used in observation group. The serum liver function index, inflammatory factors were compared, the clinical efficacy were evaluated. Results: The serum liver function index (ALT, AST, GGT) and inflammatory factor (CD40L, IL-1, IL-6 and hs-CRP) were no statistically significant difference between control group and observation group before treatment (all P0.05). Compared with the control group after treatment, serum liver function index of ALT, AST, GGT in observation group were improved more significantly (t=9.901, 5.078, 8.529, P0.05); The control group total effective rate was 67.2%, significantly less than 93.1% of the observation group (χ2=21.125,P=0.001). Serum inflammatory factors such as CD40L, IL-1, IL-6 and hs-CRP also significantly lower in observation group(t=8.512, 11.335, 6.668, 11.335, P0.05). Conclusion: Hua-Zhuo-Tong-Luo can obviously improve the clinical symptoms in patients with AH, can protect liver func

文档评论(0)

xxj1658888 + 关注
实名认证
文档贡献者

教师资格证持证人

该用户很懒,什么也没介绍

领域认证该用户于2024年04月12日上传了教师资格证

1亿VIP精品文档

相关文档